Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent

Parasite-based screening and proteome profiling reveal orlistat, an FDA-approved drug, as a potential anti Trypanosoma brucei agent

10.1002/chem.201200482

Saved in:
Bibliographic Details
Main Authors: Yang, P.-Y., Wang, M., Liu, K., Ngai, M.H., Sheriff, O., Lear, M.J., Sze, S.K., He, C.Y., Yao, S.Q.
Other Authors: CHEMISTRY
Format: Article
Published: 2014
Subjects:
antiparasite agents
drug discovery
orlistat
proteomics
trypanosomiasis
Online Access:http://scholarbank.nus.edu.sg/handle/10635/76725
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: National University of Singapore

Similar Items

Similar Items